InsidersTradesSigma
Total declarations
Companies
▲ Purchases (22 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
22
Disclosed sells
3
T+90 hit rate
81%
T+90 mean return
+24.6%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Childs John W, Director. Officer active across 4 companies, notably Veradermics, Inc. Cumulatively, 35 reports have been published. Split: 22 buys · 3 sells. Total volume traded: €130.4m. Activity tracked since 10 November 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Childs John W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
15,000 shares@ US$106.14Common StockSEC:0001628280-26-057196:0
80,000 shares@ US$107.23Common StockSEC:0001628280-26-057196:1
5,000 shares@ US$108.24Common StockSEC:0001628280-26-057196:2
28,400 shares@ US$30.42660.055% mcap50.0% of flowCommon SharesSEC:0001027035-26-000006:0
Canonical exit: 2 Jun 2025 (T+90)
294,117 shares@ US$17.000.10% mcap50.0% of flowCommon StockSEC:0001027035-26-000004:0
Canonical exit: 6 May 2026 (T+90)
480,269 sharesCommon StockSEC:0001628280-26-005906:0
3,333,333 shares@ US$7.5018.5% of flowCommon SharesSEC:0001027035-25-000004:0
Canonical exit: 11 Feb 2026 (T+90)
73,170 shares@ US$41.002.9% of flowCommon SharesSEC:0001935979-25-000017:0
Canonical exit: 21 Jul 2024 (T+90)
25,000 shares@ US$30.38590.8% of flowCommon SharesSEC:0001935979-25-000018:0
Canonical exit: 2 Jun 2025 (T+90)
29,000 shares@ US$35.94461.0% of flowCommon SharesSEC:0001935979-24-000088:0
Canonical exit: 30 Mar 2025 (T+90)
21,052 shares@ US$47.500.9% of flowCommon SharesSEC:0001935979-24-000078:0
Canonical exit: 31 Dec 2024 (T+90)
28,400 shares@ US$35.66841.0% of flowCommon SharesSEC:0001562180-24-005805:0
Canonical exit: 16 Oct 2024 (T+90)
28,000 shares@ US$35.581.0% of flowCommon SharesSEC:0001562180-24-004529:0
Canonical exit: 28 Aug 2024 (T+90)
28,500 shares@ US$35.17441.0% of flowCommon SharesSEC:0001562180-24-004011:0
Canonical exit: 11 Aug 2024 (T+90)
24,391 shares@ US$41.001.0% of flowCommon SharesSEC:0001562180-24-003494:0
Canonical exit: 21 Jul 2024 (T+90)
73,170 shares@ US$41.002.9% of flowCommon SharesSEC:0001562180-24-003494:2
Canonical exit: 21 Jul 2024 (T+90)
97,560 shares@ US$41.003.9% of flowCommon SharesSEC:0001562180-24-003494:1
Canonical exit: 21 Jul 2024 (T+90)
2,091 sharesCommon SharesSEC:0001562180-24-003337:0
19,412 sharesCommon SharesSEC:0001562180-24-002510:0
48,505 sharesCommon SharesSEC:0001562180-24-000427:0
318,000 shares@ US$22.006.9% of flowCommon SharesSEC:0001562180-23-007253:0
Canonical exit: 3 Jan 2024 (T+90)
136,545 shares@ US$22.003.0% of flowCommon SharesSEC:0001562180-23-007253:1
Canonical exit: 3 Jan 2024 (T+90)
50,000 shares@ US$18.44360.9% of flowCommon SharesSEC:0001562180-23-006632:0
Canonical exit: 28 Nov 2023 (T+90)
100,000 shares@ US$19.78431.9% of flowCommon SharesSEC:0001562180-23-006204:0
Canonical exit: 2 Nov 2023 (T+90)
2,380,952 shares@ US$10.5026.2% of flowCommon SharesSEC:0001562180-23-003045:0
Canonical exit: 23 Jan 2023 (T+90)
25 of 35 declarations
About Childs John W
CHILDS JOHN W is a Director at Biohaven Ltd., MATTRESS FIRM HOLDING CORP., Biohaven Pharmaceutical Holding Co Ltd., and Veradermics, Inc. He has 32 filings in total, and across the 32 sampled filings, the observed buys and sells run from 2016-02-05 to 2026-03-09, with buys of EUR 121091761 and sells of EUR 456885182.
